Shenzhen Neptunus Interlong Bio-technique Company Limited (HKG:8329)
0.1000
+0.0010 (1.01%)
Sep 17, 2026, 3:59 PM HKT
HKG:8329 Market Cap
HKG:8329 has a market cap or net worth of 167.8 million as of September 18, 2026. Its market cap has decreased by -37.89% in one year.
Market Cap
167.80M
Enterprise Value
97.86M
Revenue
1.05B
Ranking
n/a
PE Ratio
n/a
Stock Price
0.10
ChartMarket Cap Chart
Since September 12, 2005, HKG:8329's market cap has decreased from 345.53M to 167.80M, a decrease of -51.44%. That is a compound annual growth rate of -3.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 167.80M | -37.11% |
| Dec 31, 2025 | 266.80M | -2.45% |
| Dec 31, 2024 | 273.51M | -0.61% |
| Dec 29, 2023 | 275.19M | -4.65% |
| Dec 30, 2022 | 288.62M | -7.03% |
| Dec 31, 2021 | 310.43M | -46.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lee's Pharmaceutical Holdings | 712.49M |
| Zhongzhi Pharmaceutical Holdings | 621.79M |
| Fusen Pharmaceutical Company | 613.62M |
| Wai Yuen Tong Medicine Holdings | 384.46M |
| Regent Pacific Group | 261.18M |
| Tianda Pharmaceuticals | 258.01M |
| Extrawell Pharmaceutical Holdings | 243.60M |
| Kontafarma China Holdings | 190.01M |